查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561466

2024-2032 年按藥物類型（NSAID、DMARD、生物製劑等）、類型、給藥途徑、配銷通路和地區分類的銀屑病關節炎治療市場報告

Psoriatic Arthritis Treatment Market Report by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球乾癬性關節炎治療市場規模達97IMARC Group美元。

銀屑病關節炎是一種自體免疫疾病，免疫系統攻擊關節並引起發炎。其治療選擇多種多樣，從減少腫脹和發炎的口服藥物到針對特定免疫系統的生物療法。根據疼痛、腫脹和僵硬的程度進行治療。目前，主要參與者正在引入新的治療方法，以幫助預防疾病進展、減輕疼痛、保護關節和維持活動範圍。這些方法可以與物理治療相結合，以增強肌肉和關節並提高整體穩定性。

銀屑病關節炎治療市場趨勢：

銀屑病是乾癬性關節炎的主要危險因子之一。因此，由於感染、壓力、肥胖、皮膚損傷、酗酒和維生素缺乏而導致的牛皮癬盛行率不斷上升，是對市場產生正面影響的主要因素之一。此外，由於乾癬性關節炎最常發生在 30 歲至 50 歲之間的人群中，全球成年人口的不斷成長也促進了市場的成長。除此之外，患有乾癬性關節炎的兒童更有可能患上影響眼壁組織中層的葡萄膜炎。再加上父母對孩子健康的日益擔憂，刺激了全球對乾癬性關節炎治療的需求。此外，人們越來越認知到早期診斷和治療乾癬性關節炎的好處（例如預防嚴重損害）正在推動市場成長。其他因素，例如個人可支配收入的增加、醫療保健設施的改善以及個人健康意識的增強，預計將推動對新型乾癬性關節炎治療方法的需求，以對抗嚴重的症狀。

本報告回答的關鍵問題：

  • 迄今為止，全球乾癬性關節炎治療市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球乾癬性關節炎治療市場有何影響？
  • 主要區域市場有哪些？
  • 根據藥物類型分類的市場是怎麼樣的？
  • 依類型分類市場是怎麼樣的？
  • 根據給藥途徑，市場的分化為何？
  • 基於配銷通路的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球乾癬性關節炎治療市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球銀屑病關節炎治療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依藥物類型

  • NSAID（非類固醇抗發炎藥）
    • 市場趨勢
    • 市場預測
  • DMARD（緩解疾病的抗風濕藥物）
    • 市場趨勢
    • 市場預測
  • 生物製劑
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按類型

  • 處方
    • 市場趨勢
    • 市場預測
  • 場外交易
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依管理途徑

  • 可注射
    • 市場趨勢
    • 市場預測
  • 口服
    • 市場趨勢
    • 市場預測
  • 專題
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥局
    • 市場趨勢
    • 市場預測
  • 網路藥局
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AbbVie Inc.
    • Amgen Inc.
    • Amneal Pharmaceuticals LLC
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Eisai Co. Ltd.
    • Eli Lilly and Company
    • Johnson & Johnson Service ltd.
    • Novartis AG
    • Pfizer Inc.
    • Samsung Biologics
    • UCB SA
Product Code: SR112024A4541

The global psoriatic arthritis treatment market size reached US$ 9.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032.

Psoriatic arthritis is an autoimmune disorder wherein the immune system attacks the joints and causes inflammation. Its treatment options vary from oral medications that reduce swelling and inflammation to biological therapies that target the specific immune system. It is treated as per the level of pain, swelling, and stiffness. At present, key players are introducing new treatment methods that help prevent disease progression, reduce pain, protect joints, and preserve the range of motion. These methods can be combined with physical therapy to strengthen muscles and joints and increase overall stability.

Psoriatic Arthritis Treatment Market Trends:

Psoriasis disease is one of the major risk factors for psoriatic arthritis. As a result, the increasing prevalence of psoriasis disease due to infection, stress, obesity, skin injuries, alcohol abuse, and vitamin deficiencies represents one of the primary factors influencing the market positively. Moreover, as psoriatic arthritis occurs most commonly among individuals between the ages of 30 and 50, the rising adult population worldwide is contributing to the market growth. Apart from this, children with psoriatic arthritis are more likely to develop uveitis that affects the middle layer of tissue in the eyewall. This, in confluence with the growing concerns among parents about the health of their children, is catalyzing the demand for psoriatic arthritis treatment across the globe. In addition, the rising awareness about the benefits of early diagnosis and treatment of psoriatic arthritis, such as preventing serious damages, is bolstering the market growth. Other factors, such as inflating disposable income of individuals, improvement in healthcare facilities, and the growing health awareness among individuals, are anticipated to drive the demand for novel psoriatic arthritis treatment to combat severe symptoms.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global psoriatic arthritis treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug type, type, route of administration and distribution channel.

Breakup by Drug Type:

  • NSAIDs (Nonsteroidal Anti-Inflammatory drugs)
  • DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others

Breakup by Type:

  • Prescription
  • OTC

Breakup by Route of Administration:

  • Injectable
  • Oral
  • Topical

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Amneal Pharmaceuticals LLC, AstraZeneca plc, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Johnson & Johnson Service ltd., Novartis AG, Pfizer Inc., Samsung Biologics and UCB S.A.

Key Questions Answered in This Report:

  • How has the global psoriatic arthritis treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global psoriatic arthritis treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global psoriatic arthritis treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Psoriatic Arthritis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biologics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Prescription
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 OTC
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Amgen Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amneal Pharmaceuticals LLC
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 AstraZeneca plc
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Bristol-Myers Squibb Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Eisai Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Eli Lilly and Company
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson Service ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Samsung Biologics
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 UCB S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Psoriatic Arthritis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Psoriatic Arthritis Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Psoriatic Arthritis Treatment Market: Breakup by Drug Type (in %), 2023
  • Figure 5: Global: Psoriatic Arthritis Treatment Market: Breakup by Type (in %), 2023
  • Figure 6: Global: Psoriatic Arthritis Treatment Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Psoriatic Arthritis Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Psoriatic Arthritis Treatment Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Psoriatic Arthritis Treatment (Biologics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Psoriatic Arthritis Treatment (Biologics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Psoriatic Arthritis Treatment (Prescription) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Psoriatic Arthritis Treatment (Prescription) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Psoriatic Arthritis Treatment (OTC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Psoriatic Arthritis Treatment (OTC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Psoriatic Arthritis Treatment (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Psoriatic Arthritis Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Psoriatic Arthritis Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Psoriatic Arthritis Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Psoriatic Arthritis Treatment (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Psoriatic Arthritis Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: United States: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: United States: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Canada: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Canada: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Asia-Pacific: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Asia-Pacific: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: China: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: China: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Japan: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Japan: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: India: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: India: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: South Korea: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: South Korea: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Australia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Australia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Indonesia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Indonesia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Germany: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Germany: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: France: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: France: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: United Kingdom: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: United Kingdom: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Italy: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Italy: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Spain: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Spain: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Russia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Russia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Latin America: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Latin America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Brazil: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Brazil: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Mexico: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Mexico: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Middle East and Africa: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Middle East and Africa: Psoriatic Arthritis Treatment Market: Breakup by Country (in %), 2023
  • Figure 81: Middle East and Africa: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: Psoriatic Arthritis Treatment Industry: SWOT Analysis
  • Figure 83: Global: Psoriatic Arthritis Treatment Industry: Value Chain Analysis
  • Figure 84: Global: Psoriatic Arthritis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Psoriatic Arthritis Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 3: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 4: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Psoriatic Arthritis Treatment Market: Competitive Structure
  • Table 8: Global: Psoriatic Arthritis Treatment Market: Key Players